Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC. Issue 11 (19th September 2019)

Record Type:: Journal Article
Title:: Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC. Issue 11 (19th September 2019)
Main Title:: Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC
Authors:: Garciaz, Sylvain
Loschi, Mickael
De Masson, Adèle
Biard, Lucie
Mercier, Mélanie
Tomowiak, Cécile
Delage, Jeremy
Labussiere-Wallet, Hélène
Sibon, David
Cassuto, Ophélie
Borel, Cécile
Cornillon, Jérome
Nimubona, Stanislas
Charbonnier, Amandine
Brice, Pauline
Socié, Gérard
Bouabdallah, Reda
de Latour, Régis Peffault
de Fontbrune, Flore Sicre
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 60:Issue 11(2019)
Journal:: Leukemia & lymphoma
Issue:: Volume 60:Issue 11(2019)
Issue Display:: Volume 60, Issue 11 (2019)
Year:: 2019
Volume:: 60
Issue:: 11
Issue Sort Value:: 2019-0060-0011-0000
Page Start:: 2802
Page End:: 2805
Publication Date:: 2019-09-19
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2019.1599112 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 17162.xml